Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 201–250 of 33026
Yael Duffy, Donna D. Fraiche, Barbara D. Gilmore, William A. Lamkin, Timothy R. Pohl, Adam D. Portnoy, Jeffrey P. Somers and Mark A. Talley resigned as trustees of the Company.
Yael Duffy, Donna D. Fraiche, Barbara D. Gilmore, William A. Lamkin, Timothy R. Pohl, Adam D. Portnoy, Jeffrey P. Somers and Mark A. Talley resigned as trustees of the Company.
Yael Duffy, Donna D. Fraiche, Barbara D. Gilmore, William A. Lamkin, Timothy R. Pohl, Adam D. Portnoy, Jeffrey P. Somers and Mark A. Talley resigned as trustees of the Company.
replacing Brian Nelson.
On June 16, 2026, Fidelity Bank (the “ Bank ”) and its holding company FB Bancorp, Inc. (the “ Company ”) informed Mr. Randall L. Baker, Chief Operating Officer, that he would be separated from the Bank effective as of June 16, 2026.
On June 18, 2026, Andrew Wattula, Chief Operating Officer, notified Hudson Pacific Properties, Inc. (the “Company”) of his resignation.
On June 18, 2026, Jeffrey Howowitz gave notice that he will retire as Chief Compliance Officer of BitGo Holdings, Inc. (the “ Company ”), effective June 19, 2026.
Effective June 19, 2026, Mark Child resigned from the board of directors (the “ Board ”) of Bunker Hill Mining Corp. (the “ Registrant ”).
Kevin J. Wheeler will retire as Executive Chairman of the Company.
On June 22, 2026, Guardian Pharmacy Services, Inc. (the “Company”) announced that Kendall Forbes, who has served as Executive Vice President of Sales & Operations since the Company was founded in 2004, will retire from all positions with the Company effective July 1, 2026.
On June 22, 2026, the Company announced that Jeremy Kinch, the Company’s Chief Operating Officer (“COO”) departed the Company effective the same date.
On June 16, 2026, the Company and Mr. Needham entered into a Retirement, Separation, Waiver and Release Agreement (the “Retirement Agreement”) in connection with Mr. Needham’s retirement from employment with the Company, effective June 20, 2026.
On June 17, 2026, Mary A. Tidlund notified the registrant of her decision to resign as a director of the registrant.
On June 17, 2026, Mary A. Tidlund notified the registrant of her decision to resign as a director of the registrant. Her resignation from the board of directors of the registrant will be effective on June 30, 2026 and did not result from any disagreement with the registrant.
Panos Kozanian, Executive Vice President of Product Engineering of the Company, have mutually agreed to begin a transition with respect to Mr. Kozanian’s responsibilities, effective June 29, 2026.
Best Buy Co., Inc. (the “Company” or “registrant”) announced that Matt Bilunas, the Company’s Senior Executive Vice President, Chief Financial Officer and Enterprise Strategy, will depart the Company effective July 31, 2026.
On June 22, 2026, Arvinas, Inc., a Delaware corporation (the “Company”), and Noah Berkowitz, M.D., Ph.D., the Company’s chief medical officer, agreed that Dr. Berkowitz would depart from his employment with the Company, effective July 3, 2026 (the “Departure”).
Howard Wilson, who has served as the CFO of the Company since 2016, has ceased serving as CFO on the Appointment Date, as previously disclosed.
Michael H. Schwerdtman, Senior Vice President, Chief Accounting Officer (Principal Accounting Officer) notified the Company that he was retiring from his position, effective as of the Effective Date
On June 16, 2026, Michelle Doig notified BridgeBio Oncology Therapeutics, Inc. (the “Company”), of her resignation as a member of the Board of Directors of the Company (the “Board”) upon the completion of her term as a Class I director, effective as of June 16, 2026, the date of the Company’s 2026 Annual Meeting of Stockholders (the “Annual Meeting”).
Russell J. Weiner informed Domino’s Pizza, Inc. (the “Company”) that he will retire as the Company’s Chief Executive Officer effective at 11:59 p.m. ET on September 30, 2026.
David A. Brandon has informed the Company that he will not stand for re-election to the Board at the Company’s 2027 annual meeting of shareholders and will retire from the Board and his employment with the Company effective as of the expiration of his current term on or about April 27, 2027.
Mr. Eitan Ajchenbaum was not re-elected to the Board and therefore ceased to serve as a director and as a member of the respective committees on which he served, effective from the close of day of the 2026 Annual Meeting.
On the same date, Mr. Yee resigned from the Board.
the Company notified Brian Ragsdale that his contract with the Company would not be renewed and would terminate effective August 11, 2026.
On June 15, 2026, Laurent Degryse, William Petak, Keith Hall and Peter McMillan III each notified the board of directors (the “Board”) of Pacific Oak Strategic Opportunity REIT, Inc. (the “Company”) of their decision to resign from the Board, effective immediately.
On June 15, 2026, Laurent Degryse, William Petak, Keith Hall and Peter McMillan III each notified the board of directors (the “Board”) of Pacific Oak Strategic Opportunity REIT, Inc. (the “Company”) of their decision to resign from the Board, effective immediately.
On June 15, 2026, Laurent Degryse, William Petak, Keith Hall and Peter McMillan III each notified the board of directors (the “Board”) of Pacific Oak Strategic Opportunity REIT, Inc. (the “Company”) of their decision to resign from the Board, effective immediately.
On June 15, 2026, Laurent Degryse, William Petak, Keith Hall and Peter McMillan III each notified the board of directors (the “Board”) of Pacific Oak Strategic Opportunity REIT, Inc. (the “Company”) of their decision to resign from the Board, effective immediately.
On June 15, 2026, James Hendrickson, the President and Chief Operating Officer of Verses AI Inc. (the “Company”) informed the Company’s Board of Directors (the “Board”) that he was resigning as the President and Chief Operating Officer effective immediately.
Mr. Johnson will step down from those roles effective as of June 30, 2026.
On June 17, 2026, Michael Buhle ceased serving as Chief Executive Officer of Aspira Women's Health Inc. (the "Company").
On June 16, 2026, the Company received separate notices from each of Director David Wodlinger and Director Henry Albers informing the Company of their resignation from the Company’s Board effective June 17, 2026.
On June 16, 2026, the Company received separate notices from each of Director David Wodlinger and Director Henry Albers informing the Company of their resignation from the Company’s Board effective June 17, 2026.
On June 15, 2026, Axel André, Executive Vice President and Chief Financial Officer of Reinsurance Group of America, Incorporated (the “Company”), informed the Company of his resignation from the Company effective July 17, 2026.
On June 22, 2026, the Company announced that Marc Winterhoff, Chief Operating Officer, has departed the Company, effective immediately following the elimination of the Chief Operating Officer position.
On June 18, 2026, Steve Kelsey, M.D., FRCP, FRCPath, informed Revolution Medicines, Inc. (the “Company”) of his intent to retire from his employment with the Company effective as of January 4, 2027.
On June 17, 2026, Allison W. Brady, a member of the Board of Directors (the “Board”) of Jupiter Neurosciences, Inc. (the “Company”), informed the Company of her decision to resign from the Board, effective immediately.
On June 18, 2026, John W. Swann III, President, Detection and Measurement Segment of SPX Technologies, Inc. (the “Company”), informed the Company of his decision to retire in January 2027.
On June 16, 2026, Dionne Pendleton notified the Board of Directors (the “Board”) of Sentient Brands Holdings Inc. (the “Company”) of her resignation, effective June 16, 2026, from her positions as a member of the Board and as Corporate Secretary and Treasurer of the Company.
Effective June 15, 2026 T, Benjamin (Ben) Jennings will no longer serve as Chairman of the Board of Directors of Panamera Holdings Corporation.
On June 17, 2026, C. Raymond Larkin, Jr. notified the Board of Directors (the “Board”) of Align Technology, Inc. (the “Company”) that he will retire as Chairman of the Board effective July 1, 2026, and as a member of the Board effective December 31, 2026.
On June 12, 2026, Rich Hossfeld notified ESS Tech, Inc. (the “Company”) that he is resigning from the board of directors (the “Board”) of the Company and Audit Committee of the Board (the “Audit Committee”), effective as of June 12, 2026.
On June 13, 2026, Mario Manzo notified the Board of Directors (the “Board”) of Ulixe Corp. (the “Company”) of his resignation as a member of the Board, effective immediately.
Effective June 16, 2026 (the “Effective Date”), James Cabral ceased serving as Chief Operating Officer of SpringBig Holdings, Inc. (the “Company”) and is no longer employed by the Company.
Todd P. Helms, Senior Vice President and Chief Human Resources Officer of Mueller Water Products, Inc. (the “Company”), will be departing the Company effective September 1, 2026.
On June 16, 2026, USA Rare Earth, Inc. (the “Company”) decided to end its relationship with David Kronenfeld, the Company’s general counsel, pursuant to a transition and separation agreement (the “Transition and Separation Agreement”) according to which Mr. Kronenfeld’s employment will end on August 7, 2026,
On June 18, 2026, Petros Pharmaceuticals, Inc. (the “Company”) and Mitchell Arnold, who served as the Company’s Vice President of Finance, Principal Accounting Officer and Principal Financial Officer, mutually agreed to the separation of Mr. Arnold from such roles, effective as of June 18, 2026
Vishwas Setia was separated as the Chief Financial Officer of MapLight Therapeutics, Inc. (the “Company”), effective immediately, following a review of a human resources violation.
On June 16, 2026, Fidelity National Information Services, Inc. (the “Company”) and Caroline Tsai agreed that Ms. Tsai will step down as the Company’s Chief Legal & Corporate Affairs Officer and Corporate Secretary, effective as of July 1, 2026.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.